GlobeImmune (United States)

GlobeImmune (United States)

GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlobeImmune (United States), United States, covering academic research published from 2002 to 2020. Read More.


Open Access Percentage

48%


Total
Publications

54


Total Open
Publications

26


Total
Citations

3.2K


Open Access
Percentage

48%


Total
Publications

54


Total Open
Publications

26


Total
Citations

3.2K

Wikipedia

Website

download

Breakdown

11% 20% 17% 52%

Publisher Open

11%

Both

20%

Other Platform Open

17%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01234567891011Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

4

Hybrid 12%

2

No Guarantees 65%

11

Other Platform Open

Domain 90%

18

Public 20%

4

Other Internet 10%

2

Institution 5%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
18
Europe PMC
Domain
14
Figshare
Public
4
Semantic Scholar
Public
2
unimore.it OAI-PMH Repository
Institution
1
DOI
Other Internet
1
CiteSeer X
Other Internet
1
1 / 1

Data updated 7 October 2024

Share

Share

Share